Track ImmunoPrecise Antibodies Ltd. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ImmunoPrecise Antibodies Ltd. IPA · Stock Open ImmunoPrecise Antibodies Ltd. in new tab

1.62 USD
Add to portfolio
EPS
-0.66
P/B
4.04
ROE
-101.96
Beta
0.49
Target Price
4.00 USD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
EPS-0.66
Book Value0.51
Price to Book4.04
Debt/Equity56.73
% Insiders9.066%
Growth
Revenue Growth0.08%
Estimates
Forward P/E-12.94
Forward EPS-0.16
Target Mean Price4.00

DCF Valuation

Tweak assumptions to recompute fair value for ImmunoPrecise Antibodies Ltd. (IPA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ImmunoPrecise Antibodies Ltd. Logo ImmunoPrecise Antibodies Ltd. Analysis (IPA)

Canada Health Care Official Website Stock

Is ImmunoPrecise Antibodies Ltd. a good investment? ImmunoPrecise Antibodies Ltd. (IPA) is currently trading at 1.62 USD. Market analysts have a consensus price target of 4.00 USD. This suggests a potential upside from current levels.

Investor FAQ

Does ImmunoPrecise Antibodies Ltd. pay a dividend?

No, it does not currently pay a dividend.

What asset class is ImmunoPrecise Antibodies Ltd.?

ImmunoPrecise Antibodies Ltd. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

Company Profile

MindWalk operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Exchange Ticker
NMS (United States) IPA
VAN (Canada) IPA.V
FRA (Germany) TQB.F
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Sept. 13, 2011 1:10
Sept. 2, 2016 0.33
Nov. 23, 2020 1:5
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion